trial

Antismoking Effects of Electronic Cigarettes in Subjects With Schizophrenia and Their Potential Influence on Cognitive Functioning.

NCTId NCT01979796
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Withdrawn
Enrollment 0 (actual)
Sponsored by University of Catania
Primary completion 2023-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Withdrawn
Enrollment
0 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2022-12
Primary completion
2023-12
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Ecig 24 mg nicotineEcig 0 mg nicotineNicotine free inhalator

Sponsors

University of CataniaLead Sponsor

Investigators

3
Pasquale Caponnetto, Assis ProfPrincipal Investigator
Eugenio Aguglia, ProfessorPrincipal Investigator
Giuseppe Minutolo, Assis profPrincipal Investigator

Sites

0 total

Facts & assertions

4 sourced
Enrollment
0
Phase
NA
Primary Completion Date
2023-12
Status
WITHDRAWN
relationships
The graph out of here
drug
Ecig 24 mg nicotine
drug
Ecig 0 mg nicotine
drug
Nicotine free inhalator
drug
lead_sponsor
University of Catania
company
indication
Tobacco Smoking in Schizophrenic Patients
indication
Schizophrenia
indication
Behavior, Addictive
indication
investigator
Pasquale Caponnetto, Assis Prof
person
Eugenio Aguglia, Professor
person
Giuseppe Minutolo, Assis prof
person